Picture of Zealand Pharma A/S logo

ZEAL Zealand Pharma A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Zealand Pharma Q1 EBIT Loss DKK 539 Mln

May 7 (Reuters) - Zealand Pharma A/S ZELA.CO:

Q1 REVENUE DKK 34 MILLION

Q1 EBIT DKK LOSS 539 MILLION VERSUS IBES ESTIMATE LOSS DKK 672.37 MILLION

2026 OUTLOOK: UNCHANGED

2026 OUTLOOK: RECOGNISES USD 700 MILLION / DKK 4.5 BILLION AS COLLABORATION REVENUE IN Q2 OF 2026

Source text: ID:nGNE7xp7g4

Further company coverage: ZELA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Zealand Pharma A/S

See all news